Literature DB >> 31576491

Prognostic score matching methods for estimating the average effect of a non-reversible binary time-dependent treatment on the survival function.

Kevin He1, Yun Li2, Panduranga S Rao3, Randall S Sung4, Douglas E Schaubel5.   

Abstract

In evaluating the benefit of a treatment on survival, it is often of interest to compare post-treatment survival with the survival function that would have been observed in the absence of treatment. In many practical settings, treatment is time-dependent in the sense that subjects typically begin follow-up untreated, with some going on to receive treatment at some later time point. In observational studies, treatment is not assigned at random and, therefore, may depend on various patient characteristics. We have developed semi-parametric matching methods to estimate the average treatment effect on the treated (ATT) with respect to survival probability and restricted mean survival time. Matching is based on a prognostic score which reflects each patient's death hazard in the absence of treatment. Specifically, each treated patient is matched with multiple as-yet-untreated patients with similar prognostic scores. The matched sets do not need to be of equal size, since each matched control is weighted in order to preserve risk score balancing across treated and untreated groups. After matching, we estimate the ATT non-parametrically by contrasting pre- and post-treatment weighted Nelson-Aalen survival curves. A closed-form variance is proposed and shown to work well in simulation studies. The proposed methods are applied to national organ transplant registry data.

Entities:  

Keywords:  Causal inference; Landmark analysis; Matching; Prognostic score; Semiparametric method; Survival function; Treatment effect

Year:  2019        PMID: 31576491     DOI: 10.1007/s10985-019-09485-x

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  5 in total

1.  Length-biased semi-competing risks models for cross-sectional data: an application to current duration of pregnancy attempt data.

Authors:  Alexander C McLain; Siyuan Guo; Jiajia Zhang; Thoma Marie
Journal:  Ann Appl Stat       Date:  2021-07-12       Impact factor: 1.959

2.  Clinical Utility in Adopting Race-free Kidney Donor Risk Index.

Authors:  Mona D Doshi; Douglas E Schaubel; Yuwen Xu; Panduranga S Rao; Randall S Sung
Journal:  Transplant Direct       Date:  2022-06-17

3.  Black Race Is Associated With Higher Rates of Early-Onset End-Stage Renal Disease and Increased Mortality Following Liver Transplantation.

Authors:  Meagan Alvarado; Douglas E Schaubel; K Rajender Reddy; Therese Bittermann
Journal:  Liver Transpl       Date:  2021-04-21       Impact factor: 6.112

4.  One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial.

Authors:  Meghan Elizabeth Sise; David Seth Goldberg; Douglas Earl Schaubel; Robert J Fontana; Jens J Kort; Rita R Alloway; Christine M Durand; Emily A Blumberg; E Steve Woodle; Kenneth E Sherman; Robert S Brown; John J Friedewald; Niraj M Desai; Samuel T Sultan; Josh Levitsky; Meghan D Lee; Ian A Strohbehn; J Richard Landis; Melissa Fernando; Jenna L Gustafson; Raymond T Chung; Peter Philip Reese
Journal:  Kidney Int Rep       Date:  2021-12-01

Review 5.  Matching with time-dependent treatments: A review and look forward.

Authors:  Laine E Thomas; Siyun Yang; Daniel Wojdyla; Douglas E Schaubel
Journal:  Stat Med       Date:  2020-04-03       Impact factor: 2.373

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.